Eulav Asset Management Cooper Companies, Inc. Transaction History

Eulav Asset Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$263.81 - $337.27 $1.29 Million - $1.65 Million	-4,900 Reduced 22.17%	17,200 $4.54 Million
Q2 2022 Jul 22, 2022	SELL	$301.4 - $428.42 $783,639 - $1.11 Million	-2,600 Reduced 10.53%	22,100 $6.92 Million
Q4 2021 Feb 11, 2022	SELL	$373.53 - $434.12 $1,120 - $1,302	-3 Reduced 0.01%	24,700 $10.3 Million
Q2 2021 Aug 06, 2021	BUY	$372.36 - $412.07 $1,117 - $1,236	3 Added 0.01%	24,703 $9.79 Million
Q3 2019 Nov 12, 2019	BUY	$294.25 - $341.49 $4.38 Million - $5.09 Million	14,900 Added 152.04%	24,700 $7.34 Million
Q2 2019 Aug 05, 2019	BUY	$279.29 - $336.89 $2.74 Million - $3.3 Million	9,800 New	9,800 $3.3 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.